Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Gallbladder carcinoma (GBC) is an aggressive cancer with a poorly understood molecular basis.
• Identifying molecular drivers is crucial for developing targeted therapies and improving patient outcomes.

Purpose of the Study:

• To characterize the molecular landscape of GBC.
• To identify potential prognostic and therapeutic markers in GBC.

Main Methods:

• Utilized MSK-IMPACT, a targeted next-generation sequencing (NGS) assay analyzing 505 cancer-associated genes.
• Analyzed 244 GBC samples (primary tumors and metastases).
• Correlated genetic alterations with clinicopathologic features and overall survival, adjusting for multiple testing.

Main Results:

• The most frequent alterations were in TP53 (63%), CDKN2A (21%), ERBB2 (15%), and KRAS (11%).
• SMAD4 and STK11 variants were associated with reduced survival in metastatic GBC.
• Clinically actionable alterations were found in 35% of patients, with 18% of metastatic cases receiving targeted treatments or clinical trial enrollment.

Conclusions:

• GBC exhibits significant genetic diversity.
• Genomic profiling reveals potential prognostic and therapeutic targets, guiding the development of novel GBC therapies.